The Association for the Cannabinoid Industry (ACI) is a membership organisation for businesses committed to nurturing a safe, legal and flourishing commercial cannabis extract market in the UK and Europe.
We are funded entirely by our members. Our income is comprised of membership subscriptions, consultancy fees and collaborative projects (e.g our toxicology study).
Our vision is to create an innovative and ethical sector with the highest standards of product quality, consumer satisfaction and regulatory compliance. All our members sign up to our quality charter.
We deliver vital stewardship for this emerging sector through constructive engagement with key stakeholders and thought leaders. To find out what we’ve achieved see our list of milestones.
Meet the team
Our team of scientific, regulatory and industry leaders provide expert support and guidance to our members.
Steve Moore
Strategic Counsel
Dr Parveen Bhatarah
Regulatory and Compliance Associate
Dr Paul Duffy
Toxicology Associate
Dr Andy Yates
Pharmacy Associate
Róisín Delaney
Communications Associate
Richard Clarke
PR & Communications Advisor
Zehra Zahir
Commercial Director
Tom Risby
Business Development & Research Associate
Paul Birch
Founder
Bill Griffin
Communications Associate, Brussels
Previous
Next
Media coverage
ACI generates extensive media coverage from mainstream and trade press. See the latest coverage below.
[Jersey Evening Post] Jersey Hemp wins first legal clash
September 19, 2023
[The Grocer] How ongoing CBD legal limbo has created winners and losers
September 6, 2023
